WallStreetZenWallStreetZen

NASDAQ: UFPT
Ufp Technologies Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their UFPT stock forecasts and price targets.

Forecast return on equity

Is UFPT forecast to generate an efficient return?

Company
25.43%
Industry
23.04%
Market
61.57%
UFPT's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is UFPT forecast to generate an efficient return on assets?

Company
13.86%
Industry
12.31%
UFPT is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

UFPT earnings per share forecast

What is UFPT's earnings per share in the next 3 years based on estimates from 1 analyst?

Avg 1 year Forecast
$9.25+20.29%
Avg 2 year Forecast
$10.30+33.94%
Avg 3 year Forecast
$11.35+47.59%
UFPT's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

UFPT revenue forecast

What is UFPT's revenue in the next 3 years based on estimates from 1 analyst?

Avg 1 year Forecast
$593.0M+17.56%
Avg 2 year Forecast
$635.7M+26.03%
Avg 3 year Forecast
$681.9M+35.18%
UFPT's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

UFPT earnings growth forecast

How is UFPT forecast to perform vs Medical Devices companies and vs the US market?

Company
15.73%
Industry
23.92%
Market
22.32%
UFPT's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
UFPT's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
UFPT's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

UFPT revenue growth forecast

How is UFPT forecast to perform vs Medical Devices companies and vs the US market?

Company
12.37%
Industry
8.56%
Market
10.43%
UFPT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
UFPT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

UFPT vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
UFPT$208.54N/AN/A
ATEC$10.98$17.50+59.38%Strong Buy
CNMD$49.11$71.50+45.59%Hold
QDEL$27.79$44.80+61.21%Hold
IART$16.39$25.33+54.56%Hold
View Top Medical Device Stocks

Ufp Technologies Stock Forecast FAQ

What is UFPT's earnings growth forecast for 2025-2027?

(NASDAQ: UFPT) Ufp Technologies's forecast annual earnings growth rate of 15.73% is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 23.92%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 22.32%.

Ufp Technologies's earnings in 2025 is $58,981,000.On average, 1 Wall Street analyst forecast UFPT's earnings for 2025 to be $71,042,821, with the lowest UFPT earnings forecast at $71,042,821, and the highest UFPT earnings forecast at $71,042,821. On average, 1 Wall Street analyst forecast UFPT's earnings for 2026 to be $79,107,142, with the lowest UFPT earnings forecast at $79,107,142, and the highest UFPT earnings forecast at $79,107,142.

In 2027, UFPT is forecast to generate $87,171,462 in earnings, with the lowest earnings forecast at $87,171,462 and the highest earnings forecast at $87,171,462.

If you're new to stock investing, here's how to buy Ufp Technologies stock.

What is UFPT's revenue growth forecast for 2025-2027?

(NASDAQ: UFPT) Ufp Technologies's forecast annual revenue growth rate of 12.37% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.56%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.43%.

Ufp Technologies's revenue in 2025 is $504,421,000.On average, 1 Wall Street analysts forecast UFPT's revenue for 2025 to be $4,554,420,865, with the lowest UFPT revenue forecast at $4,554,420,865, and the highest UFPT revenue forecast at $4,554,420,865. On average, 1 Wall Street analysts forecast UFPT's revenue for 2026 to be $4,882,677,101, with the lowest UFPT revenue forecast at $4,882,677,101, and the highest UFPT revenue forecast at $4,882,677,101.

In 2027, UFPT is forecast to generate $5,237,199,980 in revenue, with the lowest revenue forecast at $5,237,199,980 and the highest revenue forecast at $5,237,199,980.

What is UFPT's forecast return on assets (ROA) for 2025-2027?

(NASDAQ: UFPT) forecast ROA is 13.86%, which is higher than the forecast US Medical Devices industry average of 12.31%.

What is UFPT's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: UFPT) Ufp Technologies's current Earnings Per Share (EPS) is $7.69. On average, analysts forecast that UFPT's EPS will be $9.25 for 2025, with the lowest EPS forecast at $9.25, and the highest EPS forecast at $9.25. On average, analysts forecast that UFPT's EPS will be $10.30 for 2026, with the lowest EPS forecast at $10.30, and the highest EPS forecast at $10.30. In 2027, UFPT's EPS is forecast to hit $11.35 (min: $11.35, max: $11.35).

What is UFPT's forecast return on equity (ROE) for 2025-2027?

(NASDAQ: UFPT) forecast ROE is 25.43%, which is considered strong.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.